Enzymes are biological catalysts that speed up chemical reactions in our bodies. They play a crucial role in various physiological functions. Understanding the role of enzymes can shed light on how certain medications, such as Viagra, work to treat conditions like erectile dysfunction.
Cyclic GMP phosphodiesterase is an enzyme found predominantly in the penis. Its primary role is to break down cyclic GMP, a chemical needed for an erection. This enzyme is one of the many phosphodiesterases expressed in different tissues and in different parts of the cell, all of which have different physiological functions. By inhibiting this enzyme, Viagra helps maintain an erection after the penis is stroked.
Sildenafil, the main active ingredient in Viagra, operates primarily by inhibiting phosphodiesterase 5 (PDE5). PDE5 is responsible for the breakdown of cyclic GMP in the corpus cavernosum, the tissue responsible for erections. By blocking the activity of PDE5, sildenafil causes cGMP to accumulate in the corpus cavernosum, promoting penile erection.
Phosphodiesterases (PDEs) are a diverse family of enzymes that hydrolyze cyclic nucleotides (cAMP and cGMP). Different PDEs are expressed in different tissues and in different parts of the cell, and they have different physiological functions. They play a role in various physiological functions and can influence the effectiveness and side effects of certain medications, including Viagra.
Other phosphodiesterases can cause side effects such as visual disturbances, flushing, and decreased blood pressure. For example, inhibition of these enzymes by high doses of sildenafil, as well as other PDE inhibitors like tadalafil and vardenafil, can affect the activity of NADPH-cytochrome c reductase and its protein expression.
Inhibiting phosphodiesterases can lead to a variety of side effects. For instance, using Viagra with a nitrate can cause your blood pressure to drop to dangerously low levels. It's also noteworthy that antacids and grapefruit juice may affect the absorption of sildenafil and increase its side effects.
Beyond erectile dysfunction, sildenafil is also used to treat pulmonary arterial hypertension. It does this by relaxing blood vessels in the lungs, increasing blood flow. This effect is also a result of its inhibition of PDE5, highlighting the multi-faceted role that enzymes play in the action of Viagra.
It's worth noting that certain substances can affect how sildenafil works in the body. Antacids and grapefruit juice, for instance, can affect the absorption of sildenafil and increase its side effects. Moreover, certain medications can interact with sildenafil, including those that affect liver proteins, as sildenafil is cleared predominantly by the CYP3A4 and CYP2C9 hepatic microsomal isoenzymes.
Taking Viagra correctly can improve its effectiveness.
This includes taking the pill at the right time, not on a full stomach, and avoiding excessive drug or alcohol use.Lifestyle changes and healthy habits may also improve your experience with Viagra.
16 AUGUST 2011: OUTCOME OF ARHA’S EXTRAORDINARY GENERAL MEETING
An Extraordinary General Meeting of the members of the Australian Reproductive Health Alliance (ARHA) was held on Monday August 15th 2011.
The meeting was convened to consider the resolution that, in view of the continuing financial insecurity facing the Alliance and the decision of the Parliamentary Group on Population and Development to transfer its Secretariat to another organisation, the Australian Reproductive Health Alliance cease on September 30th 2011.
The motion was passed unanimously and ARHA will cease to exist in any form after that date.
The decision to close an organisation which has achieved so much over the past 15 years was taken in sadness. The Management Committee of ARHA would like to thank all those members and supporters who have sustained us in so many ways over that time.
For more information please do not hesitate to contact Susan Stratigos, ARHA President, on +61 (0)2 6278 6948 or 0402 957 259.
Member of ACFID & Signatory to the ACFID Code of Conduct.
NGO Special Consultative Status with the Economic and Social Council of the United Nations